295 related articles for article (PubMed ID: 18424862)
21. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN).
Moiseyev VS; Põder P; Andrejevs N; Ruda MY; Golikov AP; Lazebnik LB; Kobalava ZD; Lehtonen LA; Laine T; Nieminen MS; Lie KI;
Eur Heart J; 2002 Sep; 23(18):1422-32. PubMed ID: 12208222
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy and safety of intravenous levosimendan compared with dobutamine in decompensated heart failure].
Wang L; Cui L; Wei JP; Li GP; Qi GX; Hao YM; Wang WZ; Li HM; Liu J; Jiang DJ; Zhang YD
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jun; 38(6):527-30. PubMed ID: 21033135
[TBL] [Abstract][Full Text] [Related]
23. Management of acute cardiac failure by intracoronary administration of levosimendan.
Caimmi PP; Kapetanakis EI; Beggino C; Molinari C; Giustini G; Crosio E; Reposo G; Micalizzi E; Vacca G; Grossini E
J Cardiovasc Pharmacol; 2011 Sep; 58(3):246-53. PubMed ID: 21654504
[TBL] [Abstract][Full Text] [Related]
24. Levosimendan: a new option in acute cardiac failure.
Holley AD; Ziegenfuss M
Emerg Med Australas; 2006; 18(5-6):505-9. PubMed ID: 17083641
[No Abstract] [Full Text] [Related]
25. Levosimendan: beyond its simple inotropic effect in heart failure.
Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
[TBL] [Abstract][Full Text] [Related]
26. Early experience with Levosimendan in children with ventricular dysfunction.
Namachivayam P; Crossland DS; Butt WW; Shekerdemian LS
Pediatr Crit Care Med; 2006 Sep; 7(5):445-8. PubMed ID: 16885788
[TBL] [Abstract][Full Text] [Related]
27. [Intensive care for newborns and babies of the first year of life with acute heart failure after cardiosurgical interventions].
Lobacheva GV; Khar'kin AV; Manerova AF; Dzhobava ER
Anesteziol Reanimatol; 2010; (5):23-7. PubMed ID: 21400728
[TBL] [Abstract][Full Text] [Related]
28. [Retrospective descriptive study about the use of levosimendan in children undergoing surgical correction for congenital heart disease].
Fernández de Palencia-Espinosa MA; Cárceles-Barón MD; Blázquez-Álvarez MJ; Arocas-Casañ V; de la Rubia-Nieto A
Rev Esp Anestesiol Reanim; 2012 Nov; 59(9):489-96. PubMed ID: 22980396
[TBL] [Abstract][Full Text] [Related]
29. Duration of the beneficial effects of levosimendan in decompensated heart failure as measured by echocardiographic indices and B-type natriuretic peptide.
McLean AS; Huang SJ; Nalos M; Ting I
J Cardiovasc Pharmacol; 2005 Dec; 46(6):830-5. PubMed ID: 16306809
[TBL] [Abstract][Full Text] [Related]
30. Prospective observational study of levosimendan and weaning of difficult-to-wean ventilator dependent intensive care patients.
Sterba M; Banerjee A; Mudaliar Y
Crit Care Resusc; 2008 Sep; 10(3):182-6. PubMed ID: 18798715
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular effects of the calcium sensitizer, levosimendan, in heart failure induced by rapid pacing in the presence of aortic constriction.
Udvary E; Papp JG; Végh A
Br J Pharmacol; 1995 Feb; 114(3):656-61. PubMed ID: 7735692
[TBL] [Abstract][Full Text] [Related]
32. Levosimendan and calcium sensitization of the contractile proteins in cardiac muscle: impact on heart failure.
Kota B; Prasad AS; Economides C; Singh BN
J Cardiovasc Pharmacol Ther; 2008 Dec; 13(4):269-78. PubMed ID: 19087950
[TBL] [Abstract][Full Text] [Related]
33. Effects of levosimendan in patients with left ventricular hypertrophy undergoing aortic valve replacement.
Juhl-Olsen P; Jakobsen CJ; Rasmussen LA; Bhavsar R; Klaaborg KE; Frederiksen CA; Sloth E
Acta Anaesthesiol Scand; 2015 Jan; 59(1):65-77. PubMed ID: 25348510
[TBL] [Abstract][Full Text] [Related]
34. Levosimendan improves renal outcome in cardiac surgery: a randomized trial.
Baysal A; Yanartas M; Dogukan M; Gundogus N; Kocak T; Koksal C
J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):586-94. PubMed ID: 24447501
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use.
Tasouli A; Papadopoulos K; Antoniou T; Kriaras I; Stavridis G; Degiannis D; Geroulanos S
Eur J Cardiothorac Surg; 2007 Oct; 32(4):629-33. PubMed ID: 17702589
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of levosimendan in patients with acute right heart failure: A meta-analysis.
Qiu J; Jia L; Hao Y; Huang S; Ma Y; Li X; Wang M; Mao Y
Life Sci; 2017 Sep; 184():30-36. PubMed ID: 28689804
[TBL] [Abstract][Full Text] [Related]
37. Effects of levosimendan on right ventricular function in patients with advanced heart failure.
Parissis JT; Paraskevaidis I; Bistola V; Farmakis D; Panou F; Kourea K; Nikolaou M; Filippatos G; Kremastinos D
Am J Cardiol; 2006 Dec; 98(11):1489-92. PubMed ID: 17126656
[TBL] [Abstract][Full Text] [Related]
38. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S
Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
[TBL] [Abstract][Full Text] [Related]
39. Effect of levosimendan on E/E' ratio in patients with ischemic heart failure.
Duygu H; Ozerkan F; Nalbantgil S; Zoghi M; Akilli A; Akin M; Nazli C; Ergene O
Int J Cardiol; 2008 Jan; 123(2):201-3. PubMed ID: 17316845
[TBL] [Abstract][Full Text] [Related]
40. Haemodynamic interactions of a new calcium sensitizing drug levosimendan and captopril.
Antila S; Eha J; Heinpalu M; Lehtonen L; Loogna I; Mesikepp A; Planken U; Sandell EP
Eur J Clin Pharmacol; 1996; 49(6):451-8. PubMed ID: 8706769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
